SS
Shyam Sundar Pandia
About Shyam Sundar Pandia
Data last updated:
Shyam Sundar Pandia is a Managing Director at Medulla Pharmaceuticals Private Limited (since 2016). The company operates in Healthcare. Medulla Pharmaceuticals Private Limited reported revenue of ₹3.04 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medulla Pharmaceuticals Private Limited U24230OR2016PTC019823 | Managing Director | 22 Jan 2016 | 2016 | ₹3.04 Cr (FY 2025) | Active |
Board colleagues of Shyam Sundar Pandia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjali Pandia | 10588748 | Medulla Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shyam Sundar Pandia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shyam Sundar Pandia
Shyam Sundar Pandia currently holds 1 directorship: Medulla Pharmaceuticals Private Limited (Managing Director, since 22 Jan 2016, revenue ₹3.04 Cr (FY 2025)).
Shyam Sundar Pandia was first appointed on 22 Jan 2016 as Managing Director at Medulla Pharmaceuticals Private Limited.
The current boards of Shyam Sundar Pandia's companies include Anjali Pandia (Medulla Pharmaceuticals Private Limited).